Company Filing History:
Years Active: 2008
Title: Innovations of Stephen Patrick Lewis
Introduction
Stephen Patrick Lewis is an accomplished inventor based in Mountlake Terrace, Washington. He has made significant contributions to the field of biological signal transduction through his innovative work. His research focuses on the modulation of biological processes using small interfering RNA (siRNA) polynucleotides.
Latest Patents
Stephen holds a patent for "Modulation of biological signal transduction by RNA interference." This invention provides compositions and methods related to siRNA polynucleotides that interfere with the expression of protein tyrosine phosphatase (PTP) class enzymes. These enzymes play a crucial role in mediating signal transduction pathways. The siRNA polynucleotides developed by Stephen can modulate pathways involving SHP2, cdc14a/b, cdc25A/B/C, and others. This innovation has potential applications in treating diseases associated with cell proliferation, differentiation, and survival, including metabolic disorders, cancer, autoimmune diseases, and inflammatory disorders.
Career Highlights
Stephen is currently associated with Ceptyr, Inc., where he continues to advance his research in the field of RNA interference. His work has garnered attention for its potential to impact various medical conditions significantly.
Collaborations
Stephen collaborates with Richard Klinghoffer, contributing to the innovative research environment at Ceptyr, Inc.
Conclusion
Stephen Patrick Lewis is a notable inventor whose work in RNA interference has the potential to revolutionize treatments for various diseases. His contributions to biological signal transduction are paving the way for future innovations in medicine.